Diagnostics names react to surveillance data
A mild move, driven by wastewater and hospitalisation trends.
Event on Sep 26 · in 9 days
The prediction, in plain language
Markets say noMarkets bet the other way — they expect a setback or a refusal.
Prices imply 20% for this outcome, weakening by 7 points in 24h, with low confidence.
Treat this as a weak indication, not a forecast: confidence is low and the reading moves a lot.
This is what market prices currently imply — not a certainty. Readings change as new information arrives.
-7 / 24h
Confidence: Low
Sign in to follow this signal and set alerts.
Sign inWhy this signal
Data — Vaccine equities strengthened by 2 points over 24 hours, with volume above its 30-day average. Cross-checked against 2 linked markets.
Context — Drug pipelines and reimbursement decisions drive the sector's repricing.
Interpretation — Taken together, prices point to an implied probability of 22% and a signal strength of 44/100 on this event.
Uncertainty — Confidence is low. This is what prices imply today, not a forecast — a single surprise can reverse it.
Cross-market confirmation
Diagnostics
+1.1%
What could change it
- Surveillance reports
- Vaccine contracts
Follow the story
Loading the latest headlines…